Briefing Information for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance.
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
Merck Sharp and Dohme Corporation
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.